Cellvax Therapeutics Inc
1 clinical trials · Sponsor
◉ Watch Cellvax Therapeutics Inc
| Record | Firm | Date |
|---|---|---|
| FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer (NCT06636682) | Cellvax Therapeutics Inc | 2024-10-14 |
Track Cellvax Therapeutics Inc automatically
Every clearance here is in the API, with alerts when new ones post.